Organogenesis Holdings(DE:2PQ)
€0.81+0.03 (+3.18%)
DE:2PQ
Organogenesis Holdings financials statements
€0.81
At close:+0.03 (+3.18%)
Organogenesis Holdings (2PQ) Ratios
1 Followers
Organogenesis Holdings Ratios
DE:2PQ's free cash flow for Q3 2026 was $-20.06M. For the 2026 fiscal year, DE:2PQ's free cash flow was decreased by $-1.47M and operating cash flow was $-18.59M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.62 | 3.69 | 2.80 | 2.97 | 2.74 |
| Quick Ratio | 3.32 | 3.35 | 2.44 | 2.64 | 2.44 |
| Cash Ratio | 0.94 | 1.75 | 1.30 | 1.37 | 1.38 |
| Solvency Ratio | 0.39 | 0.16 | 0.16 | 0.18 | 0.55 |
| Operating Cash Flow Ratio | -0.10 | 0.18 | 0.38 | 0.33 | 0.75 |
| Short-Term Operating Cash Flow Coverage | -0.55 | 0.00 | 5.64 | 5.48 | 23.34 |
| Net Current Asset Value | $ 197.38M | $ 173.37M | $ 43.68M | $ 38.92M | $ 25.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.09 | 0.26 | 0.28 | 0.30 |
| Debt-to-Equity Ratio | 0.31 | 0.11 | 0.43 | 0.47 | 0.55 |
| Debt-to-Capital Ratio | 0.23 | 0.10 | 0.30 | 0.32 | 0.35 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.00 | 0.18 | 0.20 | 0.23 |
| Financial Leverage Ratio | 1.38 | 1.29 | 1.65 | 1.69 | 1.84 |
| Debt Service Coverage Ratio | 3.43 | 12.58 | 3.98 | 5.43 | 11.94 |
| Interest Coverage Ratio | 0.00 | -0.83 | 5.72 | 11.10 | 9.98 |
| Debt to Market Cap | 0.11 | 0.00 | 0.12 | 0.20 | 0.06 |
| Interest Debt Per Share | 1.05 | 0.34 | 0.93 | 0.97 | 1.09 |
| Net Debt to EBITDA | 0.53 | -5.85 | 0.42 | 0.53 | 0.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 75.57% | 75.99% | 75.42% | 76.71% | 75.57% |
| EBIT Margin | 8.34% | -0.26% | 2.90% | 4.94% | 15.05% |
| EBITDA Margin | 13.13% | 3.27% | 8.32% | 8.94% | 18.61% |
| Operating Profit Margin | 9.92% | -0.27% | 2.89% | 4.95% | 15.45% |
| Pretax Profit Margin | 8.34% | -0.58% | 2.40% | 4.50% | 13.50% |
| Net Profit Margin | 6.58% | 0.18% | 1.14% | 3.44% | 20.16% |
| Continuous Operations Profit Margin | 6.58% | 0.18% | 1.14% | 3.44% | 20.16% |
| Net Income Per EBT | 78.84% | -30.67% | 47.58% | 76.58% | 149.32% |
| EBT Per EBIT | 84.07% | 218.78% | 82.97% | 90.93% | 87.35% |
| Return on Assets (ROA) | 6.19% | 0.17% | 1.07% | 3.46% | 21.25% |
| Return on Equity (ROE) | 8.53% | 0.22% | 1.77% | 5.85% | 39.03% |
| Return on Capital Employed (ROCE) | 11.21% | -0.31% | 3.30% | 5.96% | 20.03% |
| Return on Invested Capital (ROIC) | 8.52% | 0.09% | 1.49% | 4.37% | 19.25% |
| Return on Tangible Assets | 6.60% | 0.19% | 1.19% | 3.88% | 24.23% |
| Earnings Yield | 5.64% | 0.20% | 0.92% | 4.44% | 7.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.59 | 4.39 | 5.28 | 5.04 | 5.67 |
| Payables Turnover | 4.30 | 4.00 | 3.47 | 3.25 | 3.89 |
| Inventory Turnover | 4.64 | 4.41 | 3.77 | 4.24 | 4.56 |
| Fixed Asset Turnover | 3.53 | 3.82 | 2.77 | 3.10 | 3.64 |
| Asset Turnover | 0.94 | 0.97 | 0.94 | 1.00 | 1.05 |
| Working Capital Turnover Ratio | 2.39 | 2.73 | 2.97 | 3.09 | 3.73 |
| Cash Conversion Cycle | 134.81 | 74.70 | 60.63 | 46.18 | 50.60 |
| Days of Sales Outstanding | 140.97 | 83.19 | 69.10 | 72.41 | 64.40 |
| Days of Inventory Outstanding | 78.63 | 82.68 | 96.85 | 86.13 | 79.97 |
| Days of Payables Outstanding | 84.80 | 91.17 | 105.32 | 112.36 | 93.77 |
| Operating Cycle | 219.60 | 165.87 | 165.95 | 158.55 | 144.37 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.08 | 0.11 | 0.24 | 0.19 | 0.48 |
| Free Cash Flow Per Share | -0.19 | 0.03 | 0.05 | -0.07 | 0.24 |
| Dividend Paid and CapEx Coverage Ratio | -0.73 | 1.20 | 1.27 | 0.73 | 1.99 |
| Capital Expenditure Coverage Ratio | -0.73 | 1.42 | 1.27 | 0.73 | 1.99 |
| Operating Cash Flow Coverage Ratio | -0.08 | 0.33 | 0.26 | 0.20 | 0.47 |
| Operating Cash Flow to Sales Ratio | -0.02 | 0.03 | 0.07 | 0.06 | 0.13 |
| Free Cash Flow Yield | -3.73% | 0.99% | 1.22% | -2.58% | 2.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 32.38 | -450.70 | 108.54 | 22.53 | 12.59 |
| Price-to-Sales (P/S) Ratio | 1.17 | 0.87 | 1.24 | 0.78 | 2.54 |
| Price-to-Book (P/B) Ratio | 1.51 | 1.09 | 1.93 | 1.32 | 4.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -26.84 | 100.90 | 81.91 | -38.71 | 38.55 |
| Price-to-Operating Cash Flow Ratio | -63.68 | 29.66 | 17.36 | 14.07 | 19.13 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 3.79 | -1.58 | -0.27 | 0.04 |
| Enterprise Value Multiple | 9.41 | 20.88 | 15.31 | 9.21 | 13.84 |
| Enterprise Value | 695.67M | 329.10M | 551.75M | 371.20M | 1.20B |
| EV to EBITDA | 9.41 | 20.88 | 15.31 | 9.21 | 13.84 |
| EV to Sales | 1.24 | 0.68 | 1.27 | 0.82 | 2.58 |
| EV to Free Cash Flow | -28.44 | 78.81 | 84.20 | -41.07 | 39.15 |
| EV to Operating Cash Flow | -67.48 | 23.16 | 17.85 | 14.93 | 19.43 |
| Tangible Book Value Per Share | 3.12 | 2.61 | 1.78 | 1.66 | 1.46 |
| Shareholders’ Equity Per Share | 3.42 | 2.93 | 2.12 | 2.04 | 1.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 1.31 | 0.52 | 0.23 | -0.49 |
| Revenue Per Share | 4.44 | 3.66 | 3.30 | 3.47 | 3.64 |
| Net Income Per Share | 0.29 | 0.01 | 0.04 | 0.12 | 0.73 |
| Tax Burden | 0.79 | -0.31 | 0.48 | 0.77 | 1.49 |
| Interest Burden | 1.00 | 2.22 | 0.83 | 0.91 | 0.90 |
| Research & Development to Revenue | 0.08 | 0.10 | 0.10 | 0.09 | 0.07 |
| SG&A to Revenue | 0.58 | 0.61 | 0.61 | 0.62 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Income Quality | -0.28 | 16.50 | 6.25 | 1.60 | 0.65 |
Currency in USD
